BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 31622969)

  • 1. Modified Glasgow Prognostic Score as a Prognostic Factor in Patients with Extensive Disease-Small-Cell Lung Cancer: A Retrospective Study in a Single Institute.
    Sonehara K; Tateishi K; Komatsu M; Yamamoto H; Hanaoka M; Kanda S; Koizumi T
    Chemotherapy; 2019; 64(3):129-137. PubMed ID: 31622969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Baseline quality of life and performance status as prognostic factors in patients with extensive-stage disease small cell lung cancer treated with pemetrexed plus carboplatin vs. etoposide plus carboplatin.
    Reck M; Thatcher N; Smit EF; Lorigan P; Szutowicz-Zielinska E; Liepa AM; Winfree KB; Peterson P; Guba SC; Socinski MA
    Lung Cancer; 2012 Dec; 78(3):276-81. PubMed ID: 23043970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A systemic inflammation-based prognostic scores (mGPS) predicts overall survival of patients with small-cell lung cancer.
    Zhou T; Hong S; Hu Z; Hou X; Huang Y; Zhao H; Liang W; Zhao Y; Fang W; Wu X; Qin T; Zhang L
    Tumour Biol; 2015 Jan; 36(1):337-43. PubMed ID: 25256672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lung immune prognostic index as a prognostic factor in patients with small cell lung cancer.
    Sonehara K; Tateishi K; Komatsu M; Yamamoto H; Hanaoka M
    Thorac Cancer; 2020 Jun; 11(6):1578-1586. PubMed ID: 32286017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prognostic factors in the elderly patients with small cell lung cancer: a retrospective analysis from a single cancer institute.
    Liu S; Guo H; Kong L; Li H; Zhang Y; Zhu H; Yu J
    Int J Clin Exp Pathol; 2015; 8(9):11033-41. PubMed ID: 26617821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peripheral-type small cell lung cancer is associated with better survival and higher frequency of interstitial lung disease.
    Kanaji N; Sakai K; Ueda Y; Miyawaki H; Ishii T; Watanabe N; Kita N; Kadota K; Kadowaki N; Bandoh S
    Lung Cancer; 2017 Jun; 108():126-133. PubMed ID: 28625624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prognostic values of prognostic nutritional index in extensive-stage small-cell lung cancer.
    Bahçeci A; Kötek Sedef A; Işik D
    Anticancer Drugs; 2022 Jan; 33(1):e534-e540. PubMed ID: 34407045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic differences between oligometastatic and polymetastatic extensive disease-small cell lung cancer.
    Shirasawa M; Fukui T; Kusuhara S; Harada S; Nishinarita N; Hiyoshi Y; Ishihara M; Kasajima M; Igawa S; Yokoba M; Mitsufuji H; Kubota M; Katagiri M; Sasaki J; Naoki K
    PLoS One; 2019; 14(4):e0214599. PubMed ID: 31002722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic factors for survival in extensive stage small cell lung cancer (ED-SCLC): the importance of smoking history, socioeconomic and marital statuses, and ethnicity.
    Ou SH; Ziogas A; Zell JA
    J Thorac Oncol; 2009 Jan; 4(1):37-43. PubMed ID: 19096304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The predictive value of delta-like3 and serum NSE in evaluating chemotherapy response and prognosis in patients with advanced small cell lung carcinoma: An observational study.
    Zhu C; Huang J; Jin X; Zhang C; Zhu C; Lv M; Chen S; Du X; Feng G
    Medicine (Baltimore); 2024 Jun; 103(23):e38487. PubMed ID: 38847733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic factors affecting the risk of thoracic progression in extensive-stage small cell lung cancer.
    Fukui T; Itabashi M; Ishihara M; Hiyoshi Y; Kasajima M; Igawa S; Sasaki J; Masuda N
    BMC Cancer; 2016 Mar; 16():197. PubMed ID: 26955807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes of small cell lung cancer patients treated with cisplatin-etoposide versus carboplatin-etoposide.
    Karam I; Jiang SY; Khaira M; Lee CW; Schellenberg D
    Am J Clin Oncol; 2015 Feb; 38(1):51-4. PubMed ID: 23563211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [First-line chemotherapy and its survival analysis of 394 patients with extensive-stage small cell lung cancer in a single institute].
    Ma M; Wang M; Xu Y; Hu K; Liu H; Li L; Zhong W; Zhang L; Zhao J; Wang H
    Zhongguo Fei Ai Za Zhi; 2014 Jan; 17(1):8-14. PubMed ID: 24398308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic role of pretreatment lung immune prognostic index in extensive-stage small-cell lung cancer treated with platinum plus etoposide chemotherapy.
    Qi W; Zhao S; Chen J
    Cancer Biomark; 2021; 31(2):177-185. PubMed ID: 33896825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prognostic evaluation of nutritional indicators in patients with limited-stage small cell lung cancer].
    Zhang JQ; Wang YY; Xu KP; Qi J; Wang X; Xu LM; Liu NN; Zhao LJ; Wang P
    Zhonghua Zhong Liu Za Zhi; 2019 Dec; 41(12):937-942. PubMed ID: 31874552
    [No Abstract]   [Full Text] [Related]  

  • 16. Predictive and prognostic value of folate receptor-positive circulating tumor cells in small cell lung cancer patients treated with first-line chemotherapy.
    Shen J; Zhao J; Jiang T; Li X; Zhao C; Su C; Zhou C
    Oncotarget; 2017 Jul; 8(30):49044-49052. PubMed ID: 28467771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of post-progression survival on overall survival among patients with sensitive relapse of small cell lung cancer.
    Miura Y; Imai H; Sakurai R; Kaira K; Sunaga N; Minato K; Saito R; Hisada T
    Med Oncol; 2018 Mar; 35(4):45. PubMed ID: 29508094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of modified Glasgow prognostic score in recurrent high-grade glial tumors treated with systemic treatment.
    Alan O; Telli TA; Basoğlu T; Arikan R; Demircan NC; Ercelep O; Bozkurt S; Atasoy BM; Dane F; Yumuk PF
    Clin Neurol Neurosurg; 2020 Sep; 196():105976. PubMed ID: 32531614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of pretreatment modified Glasgow Prognostic Score in small cell lung cancer: A meta-analysis.
    Xie Y; Li H; Hu Y
    Medicine (Baltimore); 2023 Nov; 102(45):e35962. PubMed ID: 37960803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Geriatric Nutritional Risk Index as a prognostic marker in patients with extensive-stage disease small cell lung cancer: Results from a randomized controlled trial.
    Lee GW; Go SI; Kim DW; Kim HG; Kim JH; An HJ; Jang JS; Kim BS; Hahn S; Heo DS
    Thorac Cancer; 2020 Jan; 11(1):62-71. PubMed ID: 31707767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.